August 2025
1. PIRES AC, Faria I, Bajouco M, Mota D, et al
   Clozapine-Resistant Schizophrenia and Wolff-Parkinson-White Syndrome: A Case Report.
   J Clin Psychopharmacol. 2025 Aug 22. doi: 10.1097/JCP.0000000000002055.
   

   >> Share

   
   October 2024
2. SKOBLE L, Kutz S, Friedman JH
   Myocarditis on Clozapine 50 mg/d in a Patient With Parkinson's Disease.
   J Clin Psychopharmacol. 2024 Oct 25. doi: 10.1097/JCP.0000000000001927.
   

   >> Share

   
   November 2023
3. BUENO L, Bermejo A, Gascon M, Gimenez-Palomo A, et al
   Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism: A Case Report.
   J Clin Psychopharmacol. 2023;43:543-546.
   

   >> Share

   
   October 2023
4. BUENO L, Bermejo A, Gascon M, Gimenez-Palomo A, et al
   Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism: A Case Report.
   J Clin Psychopharmacol. 2023 Oct 12. doi: 10.1097/JCP.0000000000001761.
   

   >> Share

   
   September 2023
5. TKACH N, Opler DJ
   A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis.
   J Clin Psychopharmacol. 2023;43:481-482.
   

   >> Share

   
   August 2023
6. TKACH N, Opler DJ
   Letter to the Editors: A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis.
   J Clin Psychopharmacol. 2023 Aug 7. doi: 10.1097/JCP.0000000000001743.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share